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Autographa californicamultiple nucleopolyhedrovirus (AcMNPV) ac146 is a highly conserved gene in the
Alpha- and Betabaculovirus genera that has an unknown function. Northern blot analysis and transcript
mapping showed that ac146 is transcribed at late times post infection as a 1.2 kb mRNA. To determine
the role of ac146 in the baculovirus life cycle ac146 knock out viruses were constructed. Transfection
and plaque assays showed that all the ac146 deletions produced a single cell phenotype indicating that
no infectious budded virus (BV) was produced, however occlusion bodies were formed. The lack of BV
production was conﬁrmed by viral titration utilizing both qPCR and TCID50. Analysis of BV and
occlusion derived virus (ODV) revealed that AC146 is associated with both forms of the virus and is
modiﬁed speciﬁcally in ODV. This study therefore demonstrates that AC146 is a late virion associated
protein and is essential for the viral life cycle.
Crown Copyright & 2012 Published by Elsevier Inc. All rights reserved.Introduction
Baculoviruses are a family of dsDNA arthropod-speciﬁc viruses
that primarily infect the insect orders Lepidoptera, Hymenoptra
and Diptera. This family has over 600 described isolates and
represents one of the largest and most diverse groups of animal
viruses (Herniou and Jehle, 2007; Herniou et al., 2003). Baculo-
viruses contain large, dsDNA genomes ranging from approxi-
mately 80 to approximately 180 kbp in size. The baculovirus
Autographa californica multiple nucleopolyhedrovirus (AcMNPV)
has a 133.9 kbp genome that has 154 predicted ORFs that are
densely packed with many genes having overlapping regulatory
sequences. One example of this is ac146 for which homologs have
been identiﬁed in all Alpha- and Betabaculovirus genera but not in
the Gamma- or Deltabaculovirus genera. The predicted ORF of
ac146, in addition to coding for AC146, also contains the upstream
promoter sequences of the essential gene ie1 (Pullen and Friesen,
1995; Theilmann and Stewart, 1991). Ie1 is also speciﬁc to the
Alpha- and Betabaculovirus genera and in conjunction with its
spliced counterpart ie0 encode the proteins that represent the
primary transregulatory genes. IE0 and IE1 proteins are essential
for the baculovirus life cycle and transactivate transcription of
early and late genes (Stewart et al., 2005). In addition, IE0 and IE1
play a critical role in initiating baculovirus DNA replication and
may act as an origin binding protein (Friesen, 1997). Ac146 lies012 Published by Elsevier Inc. All
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Theilmann).within the ie0 intron which contains 5 other genes ac141 (exon0),
ac142, ac143 (odv-e18), ac144 (odv-ec27) and ac145. Ac142, ac143,
and ac144 are all core genes and by gene knockout (KO) they have
been shown to be essential for virus development and appear to
be virion structural proteins (McCarthy and Theilmann, 2008;
Vanarsdall et al., 2007). Ac141 is Alphabaculovirus speciﬁc and is
required for nucleocapsid transport and budded virus (BV) pro-
duction (Fang et al., 2007; Fang et al., 2009b). Recently ac141 was
also shown to bind kinesin-1 a microtubule transport protein
(Danquah et al., 2012). The protein product of the Heliothis
armigera NPV homolog of ac145 has been shown to bind chitin
and an ac145 deletion was found to have reduced oral infectivity
(Lapointe et al., 2004; Wang and Zhang, 2006).
The evolutionary conservation of ac146 and its location in the
intron of ie0 would predict that this gene plays a signiﬁcant role
in the AcMNPV life cycle. To date there has not been any speciﬁc
investigations concerning ac146, but a previous study on the ie1
gene region (Guarino and Summers, 1987) suggested that ac146
may be transcribed late as a 1.2 kb transcript. The AcMNPV ac146
ORF encodes a predicted 201 amino acid protein that has not been
reported to have any homologies to known proteins other than
baculovirus homologs. The objective of this study was to char-
acterize the role of this highly conserved gene in the baculovirus
life cycle. Ac146 was conﬁrmed to be a late gene through
transcriptional analysis and its function was examined by con-
structing a series of recombinant ac146KO and repair baculo-
viruses and comparing their replication to wild-type (WT) virus.
The results showed that AC146 is essential for the viral life cycle
as it is required for the production of budded virus even though
viral DNA replication and late gene expression are unaffected.rights reserved.
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Bioinformatics analysis
Examination of all sequenced baculovirus genomes revealed
the presence of homologs of AcMNPV ac146 in all alphabaculo-
viruses and betabaculoviruses but not in gammabaculovirusesFig. 1. Conservation of ac146 within the baculovirus genera. (A) Schematic diagram sho
of representative viruses from the four baculovirus genera. Ac146 is conserved in all a
gammaviruses. (B) Protein alignment of AC146 and representative homologs showing a
serine residue at position 52 (indicated by *) is a predicted phosphorylation site that
highlighted in yellow indicate amino acids that are identical in all known AC146 homo
areas that have conservative changes or similar amino acids. Potential conserved domain
NTI (Invitrogen, Inc) using the default similarity tables. The Genbank protein sequ
NP_046300.1 for OpMNPV, YP_473199.1 for HycuNPV, NP_203570.1 for HearNPV, NP
NP_148792.1 for CpGV, NP_891855.1 for CrleGV, NP_059158.1 for XecnGV, and NP_06and deltabaculoviruses. The genomic location of ac146 has
remained consistent with respect to the 50 end of all ie1 homologs
across all alpha- and betabaculoviruses (Fig. 1A). The region 50 to
ie1 also contains the 3 baculovirus core genes ac142, ac143 (odv-
e18), and ac144 (odv-ec27), which are found in all baculovirus
genera (Fig. 1A). Gene order between baculovirus species and genera
has been shown to be highly variable (Herniou and Jehle, 2007;wing the conservation of gene organization of ac146 and the associated core genes
lpha- and betabaculoviruses but no homolog has been identiﬁed in the delta- or
mino acid sequence conservation in the Alpha- and Betabaculoviruses genera. The
is conserved in all alpha- and betabaculoviruses sequenced to date. The regions
logs including those not shown. The areas in green represent blocks of conserved
s are marked, I, II, III, IV, V, and VI. Analyses were generated using AlignX of Vector
ences used to generate the alignment proﬁle are: NP_054177.1 for AcMNPV,
_613246.1 for MacoNPV-A, NP_047652.1 for LdMNPV, NP_663172.1 for PhopGV,
8230.1 for PlxyGV.
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association of ac146 with ie1 is potentially indicative of a function
that is required for virus replication.
The predicted ac146 ORF is 606 bp and encodes a 22.9 kDa, 201
amino acid protein. An alignment of representative AC146 homologs
showing regions of sequence conservation is given in Fig. 1B. Six
generally conserved regions are observed (regions I, II, III, IV, V and
VI) but only 5 amino acids, 51–53 (VSG), 116 (W) and 157 (G) are
conserved in all known homologs (including those not shown in the
alignment). Analysis of all homologs identiﬁed only a single con-
served predicted motif which is the VSG triplet and is predicted to
be a phosphorylation site (Motif Scan, http://myhits.isb-sib.ch/
cgi-bin/motif_scan). The conservation of this motif may suggest that
phosphorylation is a necessary component of AC146 function.Ac146 transcriptional analysis
The temporal expression and transcriptional start and stop
sites of ac146 are unknown. Potential transcriptional regulatory
elements in the upstream promoter regions of ac146 include two
ATAAG late gene promoter motifs, located 342 and 399 bp
upstream of the predicted ac146 translational start site. No
baculovirus early gene motifs (TATAA–N26–28–CAGT) were iden-
tiﬁed. Two polyadenylation signals (AATAAA) were identiﬁed 299
and 345 bp downstream of the ac146 predicted translational stop
site (Fig. 2). Other regulatory sequences contained within the ORF
and promoter region of ac146 are the promoter and transcrip-
tional start site of the essential gene ie1 and the ie0 splice
acceptor site.
Ac146 was analyzed using two methods, Northern blot and 50-
and 30-RACE. This analysis was performed to determine temporal
expression of ac146 during the viral life cycle and to identify
transcriptional start and stop sites. Using a single stranded RNA
probe (Fig. 2A) the Northern blot hybridization detected two
primary transcripts, migrating at 1.2 kb and a 4.1 kb from 12 h
post infection (hpi) to 48 hpi. Maximum expression levels were
observed at 24 hpi (Fig. 2B). This observation indicates that ac146
is transcribed at late times post infection. Sequence analysis of 30-
RACE products showed that the ac146 transcript terminated 299Fig. 2. Transcriptional analysis of ac146. (A) Illustration showing the ac146 loci includin
(ATAAG) and polyadenylation sites (AATAAA). Motifs marked with a * were mapped by
acceptor site. The location of the strand speciﬁc RNA probe is shown below the ac1
determined by Northern blot and 50- and 30-RACE. The 4.1 kb arrow represents the
expression in Sf9 cells infected with AcMNPV from 3 to 48 hpi. Arrows on the left
speciﬁc probe.bases downstream of the translational stop codon at the ﬁrst
polyadenylation signal (AATAAA) (Fig. 2A). Sequencing results of
the 50-RACE products identiﬁed that ac146 transcription initiates
from the predicted ATAAG late gene promoter motif 399 bp
upstream from the translational start site of ac146 (Fig. 2A). The
RACE results showed that the ac146 transcript was 1288 nucleo-
tides in length, which was in agreement with the 1.2 kb mRNA
observed on the Northern blot. The second 4.1 kb mRNA tran-
script, which, based on the 30-RACE results uses the same
polyadenylation site as ac146, would map to the 50 end of pif5
(ac148, odv-e56, odvp-6e). Pif5 is a late gene and the OpMNPV
homolog is known to produce a 4.1 kb transcript during infection
(Braunagel et al., 1996).
Construction of AcMNPV bacmids containing ac146 gene knockouts
To analyze the function of AC146 in the viral life cycle, a ac146KO
mutant was constructed using the AcMNPV bMON14272 bacmid by
recombination with a Zeocin resistance cassette. The ac146KO virus
was designed to take into consideration that the undeﬁned promoter
of the essential gene ie1 is located within the ac146 ORF (Fig. 3A). It
was important to delete as much of the ac146 ORF as possible to
ensure that ac146 function was impaired without affecting ie1
expression. Based on the sequence analysis and transcript mapping
of ac146 the ac146KO construct was designed so that 336 bp of the ie1
promoter remained intact (Fig. 3A). The ac146KO virus was repaired
with 3 different constructs which were inserted at the polyhedrin
locus by Tn7 transposition (Fig. 3B). The KO was repaired with (i)
polyhedrin and green ﬂuorescent protein (gfp) (ac146KO2), (ii) polyhe-
drin, gfp and ac146 (ac146KO2rep), and (iii) polyhedrin, gfp and ac146
tagged with an N-terminal HA epitope tag (ac146KO2Nrep) (Fig. 3B).
The AcMNPV bMON14272 bacmid was repaired with polyhedrin and
gfp and was used as the WT virus (Fig. 3B).
Plaque assay analysis of ac146KO and repair viruses
To initially determine the effect on virus replication of
deleting ac146 from the AcMNPV genome, plaque assays were
performed on Sf9 cells transfected with bacmid DNA. Plaquesg important motifs. Indicated are the potential ac146 late transcriptional start sites
50- and 30-RACE. Also shown are the ie1 transcriptional start site and the ie0 splice
46 ORF. Arrows below the schematic show the location of the ac146 mRNA as
potential pif5 transcript that overlaps ac146. (B) Northern blot analysis of ac146
indicate the locations of the 1.2 and 4.1 kb mRNAs detected using the ac146
Fig. 3. Construction of the ac146KO virus. (A) Diagram illustrating the locations of the of the ac146KO2 deletion at the 30 end of the ORF. Also shown is a representation of
the ie1 promoter region (shown above ac146 ORF) that remains after deletion of the ac146 ORF. (B) Construction of ac146KO2 knockout, repair and WT AcMNPV bacmids.
At the ac146 locus the ac146 ORF was partially deleted by replacement with an EM7-zeocin resistance cassette via homologous recombination in E. coli. The lower portion
of the schematic illustrates the genes inserted into the polyhedrin locus to generate the ac146 repair viruses using Tn7 mediated transposition. For each virus the genes
inserted were as follows; for WT and ac146KO2 the viral genes polyhedrin and gfp were inserted; for ac146KO2Rep, polyhedrin, ac146 and gfp; for ac146KO2NRep,
polyhedrin, ac146 N-terminal HA epitope tagged and gfp.
48hpt 72 hpt 96 hpt OBs
WT
ac146KO2
ac146KO2rep
ac146KO2Nrep
gp64KO
Fig. 4. Plaque assay to analyze replication and cell to cell spread of ac146 deletion
viruses transfected into Sf9 cells. (A) Fluorescence microscopy of Sf9 cells
transfected with bacmid DNA of WT, ac146KO2, ac146KO2Rep and ac146KO2NRep
and the gp64KO control virus showing plaque sizes produced at 48, 72 and 96 hpt.
(B) Light microscopy images of OBs formed in Sf9 cells by each of the viruses
pictured in Fig. 4A. All viruses produced OBs which appear to be similar to the
WT OBs.
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expression in infected cells. Under these conditions the ac146KO2
virus was unable to produce a plaque similar to WT virus and the
ac146KO infection was restricted to a single cell indicating it was
unable to produce BV. However, the repaired ac146KO viruses,
ac146KO2rep and N-terminal HA tagged ac146KO2Nrep, produced
WT like plaques (Fig. 4A). This result demonstrates that insertion
of the ac146 ORF into an alternate locus successfully rescued BV
production and produced a secondary infection. The repair viruses
veriﬁed that deletion of ac146 was responsible for the observed
phenotype. For comparative purposes a gp64 deletion (gp64KO)
control virus was also transfected. The gp64KO virus is known not
to produce BV (Monsma et al., 1996) and is therefore restricted to
a single cell after transfection (Fig. 4A) similar to what was
observed with ac146KO. The repair virus ac146KO2Nrep included
the native ac146 30 end and polyadenylation signal which necessi-
tated the inclusion of the ac145 ORF which is transcribed in the
opposite direction to ac146 (Fig. 3B). Deletion of ac145 has been
shown to have no impact on virus replication in tissue culture
(Lapointe et al., 2004). However, to conﬁrm the observed phenotype
was due to ac146 and not due to ac145 or a dosage effect of having
two copies of ac145 two additional repair constructs (ac146KO2Op-
rep and ac146KO2Op-Crep) were made. These constructs expressed
native and HA-tagged ac146 under control of the late promoter of
the OpMNPV op146 and the AcMNPV ie2 polyadenylation signal
(Supplementary Fig. 1). No differences in BV production were
observed between ac146KO2Op-rep, ac146KO2Op-Crep and ac146K-
O2Nrep (Supplementary Fig. 4) indicating that there was no impact
of ac145 on the observed ac146KO phenotypes.
Light microscopy images at 8 days post transfection (dpt)
showed that all of the viruses produced occlusion bodies (OBs)(Fig. 4B) and had the same appearance as WT. The ac146KO2 and
gp64KO viruses only had OBs in the initially transfected Sf9 cells
in contrast to the repair and wild-type viruses which had OBs
present in virtually all cells. The appearance of OBs in all
transfected Sf9 cells demonstrates that like the gp64KO control
18 48 hpt
1 21 2
IE0
IE1
12 48 hpi
1
IE0
IE1
21 2
Fig. 5. Western blot analysis of IE1 and IE0 expression in ac146KO2 and
ac146KO2Rep in transfected and infected Sf9 cells. To assess the impact of the
ac146 deletion on the ie1 promoter (Fig. 3) the levels of IE0 and IE1 expression
were compared. Sf9 cells were (A) transfected with bacmid DNA of (1) gp64KO and
(2) ac146KO2 or (B) infected with (1) WT or (2) ac146KO2Rep. Transfected cells
were harvested at 18 and 48 hpt and infected cells were harvested at 12 and
48 hpi. The levels of IE0 and IE1 were detected using an anti-IE1 monoclonal
antibody.
Fig. 6. Time course analysis of budded virus production determined by qPCR and
TCID50 end-point dilution. Sf9 cells were transfected with ac146KO2, ac146K-
O2Nrep and WT and the supernatants was collected for analysis at 6, 12, 18, 24,
36, 48, 72 and 96 hpt. (A) Titres were determined by qPCR which estimates BV
titers regardless of virus infectivity. (B) TCID50 end-point dilution was used to
evaluate the production of infectious BV at 6 and 72 hpi. No infectious BV was
produced at 72 hpt by ac146KO2. The titers of infectious BV for ac146KO1Nrep and
WT were similar as determined by both methods.
V.L. Dickison et al. / Virology 431 (2012) 29–39 33virus, viral DNA replication must be occurring as infection
proceeded to the very late stages of viral gene expression.
In addition to ac146KO2, ac146KO2rep and ac146KO2Nrep, 17
other ac146KO deletion and repair viruses were constructed
containing larger or smaller deletions compared to ac146KO2
(Supplementary Fig. 1). All viruses were repaired with ac146 or
ac146 tagged at the N- or C-terminus with the HA epitope. All of
these additional ac146KO and repair viruses, as well as the
WT, were transfected into Sf9 cells and virus infection and spread
was visualized using ﬂuorescence microscopy (Supplementary
Fig. 2A–D). For each of the ac146KO viruses no virus spread was
observed beyond the initially transfected cells, indicating that
ac146KO viruses were not producing infectious BV and were
unable to move from cell to cell. Repair of each of the ac146KO
viruses with ac146 or with ac146 tagged with HA-epitope at
either the N- or C-terminus, resulted in all cells being infected by
72 hpt similar to WT. Plaque assays also showed that all the
ac146KO viruses produced single cell plaques but the infected
cells produced OBs (Supplementary Fig. 3). As no differences
were observed for any of the additional constructs compared
to the ac146KO2 phenotype only ac146KO2, ac146KO2rep, and
ac146KO2Nrep viruses were selected for further analysis.
IE0 and IE1 expression in ac146KO transfected Sf9 cells
As indicated above, the deletion of ac146 could impact the
expression of IE1 which could contribute to the observed phenotype.
To determine if ac146KO2 alters the expression of IE0 and IE1 the
expression levels of these two proteins were examined. Sf9 cells
were transfected with ac146KO2 and gp64KO and the levels of IE0
and IE1 expression were evaluated byWestern blot at 18 and 48 hpt
(Fig. 5A). The levels were compared to cells transfected with the
control gp64KO virus which has no alteration in the ie1 promoter but
is single cell restricted similar to ac146KO2. The results showed that
at both 18 and 48 hpt ac146KO2 had no observable impact on IE0
and IE1 expression. The levels of IE0 and IE1 were also compared in
WT or ac146KO2Rep infected cells (Fig. 5B) and similarly no impact
on expression levels was observed. This result would indicate that
the observed phenotype of ac146KO2 is not due to changes on IE1 or
IE0 expression.
Virus growth curve analysis
The plaque assay and virus infection results (Fig. 4 and
Supplementary Fig. 2) demonstrate that the loss of ac146 functionleads to a defect in BV production. To further analyze temporal
production, BV levels were determined by quantitative polymer-
ase chain reaction (qPCR) and TCID50 end-point dilution. The
plaque assay results suggested no BV was being produced;
however, it was possible that the virus being produced was
non-infectious. To address this viral genome equivalents were
measured by qPCR as this method determines virus levels
independent of infectivity. Sf9 cells were transfected with
ac146KO2, ac146KO2Nrep, and WT (TCID50 only) and at various
times post transfection the supernatant was collected and ana-
lyzed. The qPCR titers were determined at 6, 12, 15, 18, 24, 36, 48,
72 and 96 hpt. For ac146KO2 only background levels (due to
bacmid transfection) of viral DNA was detected, indicating that no
BV was produced (Fig. 6A) whereas the epitope tagged ac146K-
O2Nrep generated BV titers equivalent to WT. TCID50 end-point
dilution assays were performed at 6 and 72 hpt as well and
showed that no infectious BV was produced by ac146KO (Fig. 6B).
Ac146KO2Nrep and WT produced TCID50 levels equivalent to
those determined by qPCR which indicates that the particle to
infectious BV ratio was equivalent for both viruses.
Viral DNA replication was not affected by the deletion of ac146
The production of occlusion bodies by ac146KO2 (Fig. 4B)
indicated that viral DNA replication and very late gene expression
was occurring. To further analyze DNA replication and to deter-
mine if there was a quantitative impact on the levels of replica-
tion, qPCR was used to compare the levels of viral DNA replication
in ac146KO2, ac146KO2Nrep, WT, and gp64KO over a time course
of 6, 12, 18, 24, 36, 48, 72 and 96 hpt. The gp64KO is unable to
produce BV and spread from cell to cell but viral DNA replication
V.L. Dickison et al. / Virology 431 (2012) 29–3934is known to be unaffected (Blissard and Rohrmann, 1991). The
qPCR results showed that for ac146KO2Nrep and WT the levels of
viral DNA replication were equivalent and increased consistently
to 72 hpt (Fig. 7). For ac146KO2 and gp64KO viral DNA replication
levels were similar to the WT up to 36 hpt. After 36 hpt both
ac146KO2 and gp64KO showed only a marginal increase which is
consistent with the viruses being unable to produce BV and infect1000
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Fig. 7. Time course analysis of viral DNA replication in transfected cells. Sf9 cells
were transfected with bacmid DNA of ac146KO2, ac146KO2Nrep, gp64KO and WT.
Cells were harvested over the time course indicated and viral DNA levels were
determined by qPCR as described in Materials and methods. The gp64KO was used
as a control because it is unable to produce BV but viral DNA replication was
unaffected. Results are from two separate transfections and error bars represent
standard error.
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Fig. 8. Western blot analysis of the temporal expression and cellular localization of AC1
indicated from 6 to 96 hpi and total cell lysates were analyzed by SDS-PAGE as describe
antibody. Sizes in kDa of molecular weight markers are shown on the left. (B) Cellular lo
at 6, 24, and 48 hpi into nuclear and cytoplasmic fractions. The fractions were run o
antibodies to detect HA tagged AC146, GP64 and IE0 AND IE1, respectively. The mole
conﬁrm correct nuclear and cytoplasmic fractionation. (C) Western blot analysis of OD
AC146. Samples were separated on replicate SDS-PAGE gels. Blots were probed with an
VP39. GP64 and VP39 were analyzed to conﬁrm correct fractionation of the BV particlnew cells. These results show that viral replication levels of
ac146KO and gp64KO were comparable and therefore viral DNA
replication is unaffected by the deletion of ac146.Temporal expression and cellular expression of AC146 during
infection
The transcriptional mapping of ac146 indicated that it is a late
gene and the viral replication analysis indicated that BV production
was eliminated when ac146 was deleted. To further evaluate the
function of ac146 in the viral life cycle the temporal expression and
cellular localization of AC146 were determined. Ac146KO2Nrep
infected Sf9 cells were harvested at 6, 12, 18, 24, 36, 48, 72 and
96 hpi and analyzed by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS-PAGE) and Western blot (Fig. 8A). HA epitope
tagged AC146 was ﬁrst detected at 18 hpi and continued to increase
through to 72 hpi. At 96 hpi AC146 remained detectable but the
levels decline likely due to cell death and lysis. This result conﬁrmed
that AC146 has the expected expression proﬁle of a late gene. The
continued expression of AC146 throughout late times post infection
suggests there is an ongoing need for this viral protein when virus
assembly is occurring.
To determine AC146 cytoplasmic or nuclear localization within
cells during infection Sf9 cells were infected with ac146KO2Nrep
and harvested at 6, 24 and 48 hpi. Cells were separated into nuclear
and cytoplasmic fractions and analyzed by SDS-PAGE and Western
blot. Results showed that AC146 is present in both cytoplasmic and
nuclear fractions at 24 and 48 hpi (Fig. 8B). Surprisingly, two speciﬁc
bands in the nuclear fraction were detected at 48 hpi, the expected
23 kDa band and in addition a minor 34 kDa band. This suggests
that within the nucleus some AC146 undergoes a modiﬁcation that
produces a signiﬁcant shift in molecular mass.24 36 48 72 96 hpi
34
23
BV
34
AC146HA
34
23 23
GP64
VP39
BV ODVNCENV
46. (A) Sf9 cells were infected with ac146KO2Nrep (MOI 5), harvested at the times
d in the Materials and Methods. AC146 was detected using an anti-HA monoclonal
calization of AC146 was determined by separating ac146KO2Nrep infected Sf9 cells
n replicate SDS-PAGE gels and probed with anti-HA, -GP64 and -IE1 monoclonal
cular weights are shown on the right in kDa. GP64 and IE0–IE1 were analyzed to
V, BV and BV envelope (ENV) and nucleocapsid (NC) fractions for the presence of
ti-HA, anti-GP64 and anti-VP39 monoclonal antibodies to detect AC146, GP64 and
e in envelope and nucleocapsid fractions, respectively.
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Time course analysis showed that AC146 is expressed up to
very late times post infection at increasing levels and is trans-
ported to the nucleus. Many viral proteins with this type of
expression proﬁle are structural or virion associated. To address
the possibility that AC146 is associated with virions, BV and ODV
were puriﬁed from Sf9 cells infected with ac146KO2Nrep and
analyzed by Western blot. Additionally, BV particles were bio-
chemically fractionated into envelope and nucleocapsid fractions.
The results showed that AC146 was associated with both BV and
ODV (Fig. 8C). Analysis of the BV fractions showed that AC146
clearly separated with the nucleocapsid fraction and was not
found in the envelope fraction. Interestingly, both the 23 kDa and
the nuclear 34 kDa AC146 speciﬁc bands are observed in ODV,
with the 34 kDa being present at signiﬁcantly higher levels.
Therefore the 34 kDa form of AC146 appears to be preferentially
packaged in ODV and is excluded from BV. Previous analysis of
ODV proteins using anti-HA epitope antibody did not identify a
34 kDa protein (Fang et al., 2009a; Nie et al., 2012), indicating that
the higher molecular weight band does not represent a non-
speciﬁc cross-reaction with ODV proteins.Discussion
A homolog of the AcMNPV gene ac146 is conserved in all
sequenced baculovirus genomes in the Alpha- and Betabaculovirus
genera and it was predicted that the encoded protein would play
a key role in the viral life cycle. This study has conﬁrmed this
hypothesis and AC146 was shown to be essential in the life cycle
of AcMNPV.
Transcriptional mapping by Northern blot and 50- and 30-RACE
showed ac146 is a late gene that is expressed as a 1.2 kb mRNA
starting at 12 hpi. The pif5 4.1 kb mRNA overlaps with the ac146
mRNA and appears to be co-terminal. Western blotting indicated
that expression of AC146 mirrors the mRNA and is detectable by
12 hpi and continues up to very late times post infection.
To assess the function of AC146 in the viral life cycle ac146
knockout viruses were constructed (Fig. 3 and Supplementary
Fig. 1). Transfection of the KO viruses showed that deletion of
ac146 resulted in a virus that was unable to spread beyond the
initially transfected cell indicating that infectious BV were not
produced. The lack of BV production was conﬁrmed by titration
using both TCID50 and qPCR which showed that no BV virions
were produced regardless of their infectivity. Deletion of ac146
did not affect viral DNA replication (Fig. 7), indicating that the loss
of BV production was not due to the lack or decrease of viral DNA
levels which is known to be associated with reduced BV produc-
tion (Milks et al., 2003).
Analysis of BV and ODV also indicated that AC146 co-puriﬁed
with both virion phenotypes and appears to be associated with
the viral nucleocapsid and may be a structural protein. Western
blot analysis also showed that AC146 was observed in both the
nucleus and the cytoplasm at the predicted size of 23 kDa.
Interestingly, at late times post-infection, a second AC146 speciﬁc
band migrating at 34 kDa was also observed exclusively in the
nucleus (Fig. 8B). Analysis of BV and ODV showed that the 34 kDa
protein is the found in ODV whereas only the 23 kDa species is
observed in BV. From these results it appears that when AC146
remains in the nucleus and is incorporated into ODV it appears to
undergo a post-translational modiﬁcation that produces a nearly
10 kDa increase in size. The large shift in size is unusual and
suggests a major post-translational modiﬁcation. A change of
approximately 9–10 kDa would suggest a post-translational mod-
iﬁcations such as glycosylation (Shi and Jarvis, 2007), lipidmodiﬁcation (Guarino et al., 1995) or ubiquitination (Green
et al., 2004). AC146 does contain speciﬁc amino acid residues
required for N-glycosylation (NXS/T) but these sites are not
conserved in the AC146 homologs. AC146 also contains a con-
served predicted phosphorylation site (VSG; Fig. 1) and extensive
phosphorylation could also affect AC146 migration in protein
gels. The size shift of 9–10 kDa would agree with the addition of a
single ubiquitin molecule. Single or monoubiquination events
have been shown to direct transport of proteins to different
cellular locations and also modulate protein activity and interac-
tion (d0Azzo et al., 2005; Sadowski et al., 2011; Sloper-Mould
et al., 2001). It is tempting to speculate that the modiﬁcation of
AC146 may be involved in directing the protein or the associated
nucleocapsid to be incorporated into ODV while those destined to
become BV remain unmodiﬁed.
Western blot analysis showed that AC146 localized to the
nucleocapsid and not the envelope fractions of BV. Thus, AC146
should now be included in a group of AcMNPV nucleocapsid
proteins that are associated with both BV and ODV. These
proteins include P6.9 (Wilson et al., 1987), VP1054 (Olszewski
and Miller, 1997), AC142 (McCarthy et al., 2008), AC141 (EXON0)
(Fang et al., 2007), VP39 (Thiem and Miller, 1989), VLF-1 (Yang
and Miller, 1998), P78/83 (Russell et al., 1997), FP25 (Braunagel
et al., 1999), BV/ODV-C42 (Braunagel et al., 2001), P24 (Wolgamot
et al., 1993), P80 (Lu and Carstens, 1992), 38K (Wu et al., 2008),
ODV/BV-EC27 (Vanarsdall et al., 2007) and AC109 (Fang et al.,
2009c). Two proteomic studies of AcMNPV ODV (Braunagel et al.,
2003) and BV (Wang et al., 2010) have used a number of methods
including mass spectrometry in an attempt to identify all the
proteins associated with each virion phenotype. However, neither
study identiﬁed AC146 as an ODV or BV protein. This result is not
particularly surprising since other known ODV-associated pro-
teins were also missing from these studies and it was suggested
that their absence may be due to the masking of low-abundance
proteins by highly expressed proteins.
In conclusion, this study has shown that ac146 is an essential
late gene required for the production of BV. AC146 was also
shown to be a virion associated component of both BV and ODV
localized to the nucleocapsid fraction of BV. It is possible that
AC146 modiﬁcation may play a role in determining if the
nucleocapsid will ultimately be incorporated into ODV or BV.
Additional studies evaluating the function and structure of AC146
will be required to determine at what point in virion development
this protein is required.Materials and methods
Viruses and cells
Spodoptera frugiperda IPLB-Sf21-AE clonal isolate 9 (Sf9) insect
cells were cultured in suspension at 27 1C in TMN-FH media
(Graces medium (Gibco) supplemented TC-Yeastolate and Lactal-
bumin and 10% fetal bovine serum (Invitrogen)). The WT virus
used was AcMNPV strain E2. The AcMNPV bacmid bMON14272
(Invitrogen Life Technologies) was derived from the AcMNPV
strain E2 and maintained in DH10B cells as described previously
(Luckow et al., 1993).
Transcriptional analysis
Transcriptional analysis was performed by isolating total RNA
from AcMNPV (E2 strain) infected Sf9 cells. Cells were infected at
a multiplicity of infection (MOI) of 5 and were collected at time
points 0, 3, 6, 9, 12, 18, 24, and 48 h post infection (hpi). At each
time point 2106 cells were collected and centrifuged (300 g
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Qiagen RNeasy Kits and stored at 80 1C. RNA was quantiﬁed
by spectrophotometry and visualized by ethidium bromide
staining.
Northern blot hybridization
Total RNA (6 mg) was separated by electrophoresis in a 1.25%
agarose gel containing 6% formaldehyde (Fourney et al., 1988). RNA
was transferred to Zeta-Probe membrane (Biorad) and hybridized
using the manufacturers’ recommendations. Gene speciﬁc RNA 32P-
radiolabeled hybridization probes were made using T7 RNA poly-
merase and a 593 bp PCR product (Fig. 2) generated using primer
1814 (50-TCATAATAC GACTCACTATAGGGAGTTGCACAACACTAT-30)
containing the T7 polymerase promoter (underlined sequence) and
primer 1578 (50-GACTACGCCAACGTCAATT TATACTGCCCTAAT-30).
AcMNPV-E2 DNA was used as a template for the PCR reaction. The
PCR product was column puriﬁed followed by RNA synthesis with
T7 RNA polymerase using methods described by Sambrook and
Russell (2001). The blot was visualized by exposure to Perkin Elmer
Multisensitive Phosphorscreens, scanned using a Cyclone Phosphor
Imager (Perkin Elmer) and analyzed with Optiquant Acquisition and
Analysis Software V5.0 (Perkin Elmer).
50- and 30-RACE
Rapid ampliﬁcation of cDNA ends (RACE) was used to map the
start and stop sites for ac146. RNA was harvested at 6 and 24 hpi
from Sf9 cells infected with AcMNPV-E2 as stated above. The 50- and
30-RACE reactions were completed following the protocol outlined
in the GeneRacer Kit (Invitrogen). As speciﬁed by the manufacturer’s
protocol the extracted RNA was dephosphorylated, the mRNA cap
structure was removed and the RNA oligo provided by the Gen-
eRacer Kit was ligated to the decappedmRNA. A oligo dT primer was
then used to reverse transcribe the mRNA. The GeneRacer 50 primer
was paired with the 50 GSP1 (gene speciﬁc primer) 1744 (50-
ACATTGTATGTCGGCGGATGTTCTA-30) and with the 50 nested GSP2
1743 (50-ATTGTTATCGTGTTCGCCATTAGGG-30) to determine the
start site for ac146. The stop site for ac146 was determined by
pairing the 30 GSP1 1746 (50-CCCGACAAATTCTACG CCAAGGATT -30)
and the nested GSP2 1745 (50-TGTGCAACTGGAAACCCGCTCT TCA-
30) with the GeneRacer 30 primer. The PCR products were gel
puriﬁed using the Qiagen gel puriﬁcation kit and cloned into Topo
pCRs–Blunt Cloning Kit (Invitrogen) and sequenced with the M13
forward primer.
Construction of AcMNPV ac146 knockout bacmid
An AcMNPV bacmid (bMON14727) was used to generate four
ac146KO viruses by homologous recombination in Escherichia coli.
The regions deleted in the ac146 ORF were replaced by a 652 bp
zeocin drug resistance cassette which includes an EM7 promoter
and was produced by PCR ampliﬁcation using the plasmid
p2ZOp2A as the template. The four deletions ac146KO1,
ac146KO2, ac146KO3 and ac146KO4 utilize the common primer
1551 (50 TACGGCTCGCATGTATAGAAACTTGTTACTATGAATAAA-
GGATCTCTGC AGCACGTGTT 30) which is located at the 30 end of
the ac146 gene. Primer 1551 has a polyA signal that is used for
ac145 which is shown in italics. The underlined portion of the
primer is homologous to the EM7-zeocin resistance cassette. The
50 ends of each of the 4 deletions use different primer locations
to generate sequentially larger deletions of the ac146 ORF.
The bacmid ac146KO1 was constructed using primer 1552
(50 CGGGCATGCTAG CGCACACGGACAATGGACCCGACAAGACATGA-
TAAGATACATTGATGA 30) which leaves 500 bp upstream of the ie1
translational start site and deletes 170 bp of the 30 end of the ac146ORF. Bacmid ac146KO2 utilized primers 1551 and 1553 (50 CAA-
CAAGTACACTGCGCCGTTGGGATTTGTGGTA ACAGACATGATAAGA-
TACATTGATGA 30) and leaves 309 bp upstream of the ie1
translational start site and deletes a 285 bp of the 30 end of the
ac146 ORF. Bacmid ac146KO3 used primers 1551 and 1554
(50GGATACG AAAACAGTCGGCCGATAAACATTAATCTGAGACATGA-
TAAGATACATTGATGA 30) which left 260 bp upstream of the ie1
translational start site and deleted 410 bp of the 30 end of the ac146
ORF. Bacmid ac146KO4 was designed with primers 1551 and 1555
(50CTAAAACCAACGCGGTTATCGTTTATTTATTCAAATAGACAT GATA-
AGATACATTGATGA 30) which left 170 bp upstream of the ie1
translational start site and leaves 66 bp of the 50 end of ac146 ORF.
The PCR products containing the EM7-zeocin drug resistance
cassette with AcMNPV ﬂanking sequences were ampliﬁed using
Phusions High Fidelity Polymerase (New England Biolabs) and
gel puriﬁed using a Qiagen Gel Puriﬁcation Kits. Recombina-
tion between the PCR products and the AcMNPV bacmid
(bMON14272) was performed using the l phage Red recombinase
method described by Datsenko and Wanner (2000). Fifty ng of
gel-puriﬁed PCR product and 1 mg of bacmid DNA were cotrans-
formed into E. coli strain BW2115/pKD46. Cells were allowed to
recover in 1 ml of low salt LB in the 37 1C shaker for 4 h and then
were selected on LB agar plates that contained 50 mg/ml of
kanamycin and 30 mg/ml of zeocin. Colonies were selected and
bacmid DNA was isolated by Maxi prep Kit (Qiagen) and trans-
formed into DH10B cells (Sharma and Schimke, 1996) that
contain the Tn7 transposase helper plasmid. Cells were allowed
to recover in 1 ml of low salt LB in the 37 1C shaker for 4 h and
blue colonies selected on LB agar plates containing 50 mg/ml of
kanamycin, 30 mg/ml of zeocin, 10 mg/ml of tetracycline, 40 mg/ml
Xgal and 0.1 mM IPTG. Recombination events were conﬁrmed by
PCR using primer pairs 1574 (50 CGCCAGCTGCAAGCCTATC 30) and
520 (50 CCGGAACGGCACTGGTCAACT 30) for conﬁrmation of the
50 end of the EM7-zeocin cassette and 1575 (50 AGCTGCGC-
GAGTCTCGCTGTC 30) and 1239 (50 CTGACCGAC GCCGACCAACAC
30) for the 30 end of the EM7-zeocin cassette. Electro-competent
DH10B cells were transformed with each of the four knockout
bacmids to enable the production of Tn7 transposase repaired
viruses.
Construction of knockout, rescue and positive control bacmids
containing polyhedrin and gfp
The AcMNPV bacmid bMON14272 and each of the ac146KO
bacmids were repaired using the Tn7 transposition transfer vector
pFAcT-GFP (Dai et al., 2004). The pFAcT-GFP transfer vector
contains the polyhedrin gene, a multiple cloning site and gfp,
under control of an early promoter (Stewart et al., 2005). For each
ac146KO bacmid four repair viruses were constructed, using
pFAcT-GFP alone, with ac146, or with ac146 containing a HA
epitope tag at the N or the C termini (Fig. 3B). The ac146 gene for
the repair constructs was ampliﬁed using primers 1562 (50-
TTTTTCTAGAGAGCACAAAAACTGCTAATTTACTG-30) and 1611 (50-
TAACTCGAGCCGAATAATAAGCAGAACTAACTG-30), digested at the
restriction sites XbaI and XhoI that were synthetically incorpo-
rated into the primers, gel-puriﬁed and ligated into the pFAcT-
GFP multiple cloning site. The PCR ampliﬁed ac146 gene was also
cloned into the plasmid pBSþ (Stratagene) and used as a
template for inverse PCR to incorporate sequences to generate
an in frame HA-epitope tag (50-GGCGTAGTCGGGCACGTCG-
TAGGGGTA-30) at both the 50 and 30 ends of the ac146 ORF. The
pBSþ clones containing HA tagged fragments were digested with
XbaI and XhoI, gel puriﬁed and ligated into the pFAcT-GFP transfer
vectors.
To generate repair bacmids expressing C-terminal HA-tagged
and untagged ac146 under control of the Orgyia pseudotsugata
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nylation signal two transfer vectors were made. PCR was used to
amplify ac146 using primer pair 1936 and 1935 and AcMNPV
virus strain E2 as template. Primer 1936 (50 AACCTGCAGTTGTTT-
CATATTAAGCCACAACGCCGCCCAACATGAACGTCAATTTATACTG 30)
contains a PstI restriction site and the OpMNPV op146 promoter
that includes the late promoter motif TTAAG. Primer 1935 (50 TT-
ACTCGAGTTTTATAAAATTTATTAAAACTATGAAGAGCGGGTTTCCA 30)
contained an XhoI restriction site and the AcMNPVie2 polyA signal.
Primer pair 1936 and 1940 (50 TTACTCGAGTTTTATAAAATTTAT-
TAAAACTATGAGGCGTAGTCGGGCACGTCGTAGGGGTAAGAGCGGGTT-
TCCA 300) was used to amplify ac146 with a 30 HA tag. Primer 1940
contains an XhoI restriction site, the AcMNPV ie2 polyA signal and
sequence coding for the HA-epitope. The PCR products were digested
using XhoI and PstI, gel puriﬁed, ligated into pFAcT-GFP and trans-
formed into E. coli DH5a cells. Successful transformants were
identiﬁed by selection on LB with ampicillin (50 mg/ml) and were
conﬁrmed by restriction digestion.
The polyhedrin and gfp-positive AcMNPV bacmids were gener-
ated by Tn7-mediated transposition into electro-competent
DH10B cells containing the transposase helper plasmid and the
ac146KO bacmid DNA as described previously (Luckow et al.,
1993). Cells were recovered at 37 1C in 1 ml of low salt LB for 4 h
and plated onto low salt agar medium containing 50 mg/ml
kanamycin, 7 mg/ml gentamicin, 10 mg/ml tetracycline, 30 mg/ml
zeocin, 100 mg/ml X-Gal, and 40 mg/ml IPTG. Plates were incu-
bated at 37 1C for 48 h. White colonies were initially selected and
then restreaked onto fresh plates before being grown in overnight
cultures for bacmid DNA puriﬁcation using Qiagens Maxi Prep
columns. Puriﬁed DNA was used for PCR conﬁrmation of correct
insertions and used in transfection assays.
A control virus that has the gp64 gene deleted (Monsma et al.,
1996) and was repaired with pFAcT-GFP to generate the virus
gp64KO. The gp64KO virus therefore expresses polyhedrin and gfp
but is unable to produce infectious BV.
Transfection of Sf9 cells with bacmid derived viral DNA
Sf9 cells were plated at 1 million per well in 6-well plates and
transfected with 1.0 mg of each bacmid construct using lipofectin.
After a 4 h incubation the transfection media was removed and
cells were washed with 1.5 ml of Grace’s media. Cells were
overlaid with 1.5 ml of TMN-FH media containing 50 mg/ml of
gentamicin and incubated at 27 1C. The cells were observed under
bright light and ﬂuorescence microscopy at 24, 48, 72, and 96 hpt.
Supernates containing budded virus were collected and stored at
4 1C. Transfected cells were washed in 1X PBS (137 mM NaCl,
10 mM Phosphate, 2.7 mM KCl, pH 7.4) and cells were harvested
under sterile conditions with a rubber policeman. The cells were
pelleted by centrifugation (4 1C for 3 min at 3500 rpm), the
supernate removed and the cells stored at 80 1C.
Plaque assay
Sf9 cells (2.0106 cells/60 mm-diameter plate) were trans-
fected with 1.0 mg of each bacmid construct (ac146KO1, ac146K-
O1rep, ac146KO1Nrep, ac146KO1Crep, ac146KO2, ac146KO2rep,
ac146KO2Nrep, ac146KO2Crep, ac146KO3, ac146KO3rep, ac146K-
O3Nrep, ac146KO3Crep, ac146KO4, ac146KO4rep, ac146KO4Nrep,
ac146KO4Crep, gp64KO and WT). Cells were incubated for 2 h at
27 1C and the transfection supernatant was removed and the cells
were washed with 1 ml of Grace’s media. An overlay of 4 ml
of TMN-FH media containing 1.5% low-melting-point agarose
(Seaplaque) pre-equilibrated to 37 1C was added to each plate.
The dishes were then incubated at 27 1C for 8 days. The cells wereobserved by light and ﬂuorescence microscopy at 48, 72, 96 hpt
and 8 dpt.
BV titration using quantitative real time PCR
BV production was determined by qPCR as previously described
(Lo and Chao, 2004; McCarthy and Theilmann, 2008; Vanarsdall
et al., 2007). Sf9 cells were transfected as described above, the
supernatant was centrifuged (8000 g for 5 min) and 100 ml of each
sample was used to titer BV production. To each sample 100 ml
of lysis buffer (10 mM Tris–Cl pH 8.0, 100 mM EDTA, 0.5% SDS,
20 mg/ml RNase A and 80 mg/ml Proteinase K) were added and
incubated overnight at 50 1C. After overnight digestion total DNA
was extracted with 300 ml of phenol-chloroform, followed by 300 ml
of chloroform. The aqueous layer was removed and diluted 1/10 with
ddH2O in sterile water. To perform quantitative PCR 2 ml of diluted
DNA was added to 2X Finnzyme SYBR Master Mix (New England
Biolabs) with primers 850 (50 TTTGGCAAGGGA ACTTTGTC 30)
and 851 (50 ACAAACCTGGCAGGAGAGAG 30) which ampliﬁes a
100-bp fragment of ac126 (chitinase). A stock, of AcMNPV-E2
(2.5108 pfu/ml) that was previously titred by TCID50 end-point
dilution was serially diluted and used to develop a standard curve.
The samples were analyzed in a Stratagene MX4000 qPCR cycler
using the following conditions: 1 cycle of 95 1C for 15 min; 40 cycles
of 95 1C for 30 s, 52 1C for 24 s, 72 1C for 30 s; 1 cycle of 95 1C for
1 min; 41 cycles of 55 1C for 30 s. The results were analyzed by the
MX4000 software (McCarthy et al., 2008; Vanarsdall et al., 2007).
Production of viable BV determined by TCID50
TCID50 end-point dilution in Sf9 cells was used to determine if
infectious BV were produced as previously described (Lo and
Chao, 2004; Reed and Muench, 1937; Summers and Smith, 1987).
TCID50 was determined in triplicate at 6, 72 and 96 hpt by
infecting Sf9 cells in 96-well microtiter plates. The microtiter
plates were incubated at 27 1C for 5 days and analyzed by
ﬂuorescent microscopy (Chen et al., 2007; Reed and Muench,
1937).
DNA replication using quantitative real time PCR
Quantitative real time PCR was used to assess viral DNA
replication as previously described (McCarthy et al., 2008;
Vanarsdall et al., 2007) with some modiﬁcations. Sf9 cells were
transfected, harvested and digested as described above. To differ-
entiate between input and replicated DNA a DpnI digestion was
performed. Primers 1483 (50-CGTAGTGGTAGTAATCGCCGC-30) and
1484 (50-AGTCGAGTCGCGTCGC TTT-30) were combined with 2X
Finnzyme SYBR Master Mix (New England Biolabs) and 2 ml of
DNA template for qPCR analysis in a Stratagene MX4000 qPCR
cycler using the conditions stated above.
Time course analysis of AC146 expression
Sf9 cells (1.0106 cells/35 mm-diameter well of a six-well
plate) were infected with BV supernatant of a previously titered
stock of ac146KO2Nrep at an MOI of 5. The BV stocks were titered
using end-point dilution and qPCR. Cells were harvested at 6, 12,
18 24, 36, 48, 72 and 96 hpi and stored at 80 1C until further
analysis.
Puriﬁcation of BV and ODV
Sf9 cells were infected with ac146KO2Nrep at an MOI of 0.1 in
two 50 ml Bellco spinner ﬂasks and harvested at 5 dpi. The
harvested medium was centrifuged in 50 ml conical tubes
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puriﬁcation and the pellet was used for ODV puriﬁcation. Pur-
iﬁcation of BV, ODV and the fractionation of envelope and
nucleocapsids of BV were performed as previously described
(Braunagel and Summers, 1994; Fang et al., 2007).
Cellular localization of AC146 by nuclear and cytoplasmic
fractionation
Sf9 cells (1.0106 cells/35 mm-diamter well of a six-well
plate) were infected with BV supernatant of previously titered
stock of ac146KO2Nrep at an MOI of 5. The BV stocks were titered
using end-point dilution and qPCR. Samples were harvested at 2,
24 and 48 hpi, cells were washed with 1PBS, scraped with a
rubber policeman and centrifuged (3000 rpm for 5 min). Pellets
were resuspended in NP-40 lysis buffer (10 mM Tris [pH 7.9],
10 mM NaCl, 5 mM MgCl2, 1 mM DTT and 0.5% NP-40 [v/v]),
mixed gently and incubated on ice for 5 min. The solution was
centrifuged at 1000 g for 3 min and the supernatant containing
the cytoplasmic fraction was transferred to a fresh tube and the
pellet containing the nuclei was resuspended in NP-40 lysis
buffer. Samples were stored at 20 1C until further analysis.
Western blot
Protein samples from transfections, infections, nuclear and
cytoplasmic fractionation, puriﬁed BV and ODV were resuspended
in 2X protein sample buffer (PSB) (0.25 M Tris–Cl, pH 6.8, 4% SDS,
20% glycerol (V/V), 10% 2-mercaptoethanol, 0.05% bromophenol
blue) with protease inhibitor (Sigma P8340) and stored at 80 1C.
Protein samples were boiled for 10 min to denature and electro-
phoresed through 10% SDS-PAGE gels using a Bio Rad Mini-
Protean II apparatus and transferred to Millipore Immobilon-P
membrane with a Bio Rad liquid transfer apparatus. The blots
were probed with one of the following primary monoclonal
antibodies (MAb): (i) mouse IE1 MAb, 1:5000; (ii) mouse HA II
MAb, 1:1000; (iii) mouse OpMNPV VP39 MAb, 1:3000; (iv) mouse
GP64 AcV5 MAb, 1:250. Bound antibody was detected with
horseradish peroxidase-conjugated rabbit anti-mouse secondary
Ab, 1:10 000 and the enhanced chemiluminescence system
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